NORMAN GIBBY: Open Payments
NPI 1063864130 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,359 in 188 payments from 28 companies in 2025. Trend: 2023 $3,703 · 2024 $4,782 · 2025 $5,359
Food & beverage: $5,065Education: $294
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $838 |
| GlaxoSmithKline, LLC. | 30 | $775 |
| JAZZ PHARMACEUTICALS INC. | 18 | $724 |
| GENZYME CORPORATION | 15 | $578 |
| Verona Pharma, Inc. | 11 | $311 |
| Insmed, Inc. | 18 | $252 |
| Regeneron Healthcare Solutions, Inc. | 7 | $228 |
| Axsome Therapeutics, Inc. | 10 | $211 |
| Actelion Pharmaceuticals US, Inc. | 9 | $184 |
| Grifols USA, LLC | 8 | $183 |
Products named: DUPIXENT, XYWAV, NUCALA, TEZSPIRE, Ohtuvayre, Arikayce, Sunosi, OPSUMIT.
Industry payments across GA — which companies pay providers there.
